RELL2 nascent RNA is subjected to editing by the adenosine deaminase enzyme ADAR2, and this editing influences the ability of RELL2 to exert an anti-tumorigenic effect in ESCC cell lines [67]. The gene discussed is RELL2; the disease is esophageal squamous cell carcinoma.